SETDB1
Histone-lysine N-methyltransferase SETDB1
Also known as: ESET, KG1T, KIAA0067, KMT1E, SETB1_HUMAN, TDRD21
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15047
- Gene
- SETDB1
- Ensembl
- ENSG00000143379
- Chromosome
- 1
- Canonical length
- 1291 aa
- Protein class
- Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
This gene encodes a histone methyltransferase which regulates histone methylation, gene silencing, and transcriptional repression. This gene has been identified as a target for treatment in Huntington Disease, given that gene silencing and transcription dysfunction likely play a role in the disease pathogenesis. Alternatively spliced transcript variants of this gene have been described.[provided by RefSeq, Jun 2011]
Canonical amino-acid sequenceUniProt
1291 residues, UniProt reviewed canonical sequence.
>Q15047|SETDB1
1 MSSLPGCIGL DAATATVESE EIAELQQAVV EELGISMEEL RHFIDEELEK MDCVQQRKKQ
61 LAELETWVIQ KESEVAHVDQ LFDDASRAVT NCESLVKDFY SKLGLQYRDS SSEDESSRPT
121 EIIEIPDEDD DVLSIDSGDA GSRTPKDQKL REAMAALRKS AQDVQKFMDA VNKKSSSQDL
181 HKGTLSQMSG ELSKDGDLIV SMRILGKKRT KTWHKGTLIA IQTVGPGKKY KVKFDNKGKS
241 LLSGNHIAYD YHPPADKLYV GSRVVAKYKD GNQVWLYAGI VAETPNVKNK LRFLIFFDDG
301 YASYVTQSEL YPICRPLKKT WEDIEDISCR DFIEEYVTAY PNRPMVLLKS GQLIKTEWEG
361 TWWKSRVEEV DGSLVRILFL DDKRCEWIYR GSTRLEPMFS MKTSSASALE KKQGQLRTRP
421 NMGAVRSKGP VVQYTQDLTG TGTQFKPVEP PQPTAPPAPP FPPAPPLSPQ AGDSDLESQL
481 AQSRKQVAKK STSFRPGSVG SGHSSPTSPA LSENVSGGKP GINQTYRSPL GSTASAPAPS
541 ALPAPPAPPV FHGMLERAPA EPSYRAPMEK LFYLPHVCSY TCLSRVRPMR NEQYRGKNPL
601 LVPLLYDFRR MTARRRVNRK MGFHVIYKTP CGLCLRTMQE IERYLFETGC DFLFLEMFCL
661 DPYVLVDRKF QPYKPFYYIL DITYGKEDVP LSCVNEIDTT PPPQVAYSKE RIPGKGVFIN
721 TGPEFLVGCD CKDGCRDKSK CACHQLTIQA TACTPGGQIN PNSGYQYKRL EECLPTGVYE
781 CNKRCKCDPN MCTNRLVQHG LQVRLQLFKT QNKGWGIRCL DDIAKGSFVC IYAGKILTDD
841 FADKEGLEMG DEYFANLDHI ESVENFKEGY ESDAPCSSDS SGVDLKDQED GNSGTEDPEE
901 SNDDSSDDNF CKDEDFSTSS VWRSYATRRQ TRGQKENGLS ETTSKDSHPP DLGPPHIPVP
961 PSIPVGGCNP PSSEETPKNK VASWLSCNSV SEGGFADSDS HSSFKTNEGG EGRAGGSRME
1021 AEKASTSGLG IKDEGDIKQA KKEDTDDRNK MSVVTESSRN YGYNPSPVKP EGLRRPPSKT
1081 SMHQSRRLMA SAQSNPDDVL TLSSSTESEG ESGTSRKPTA GQTSATAVDS DDIQTISSGS
1141 EGDDFEDKKN MTGPMKRQVA VKSTRGFALK STHGIAIKST NMASVDKGES APVRKNTRQF
1201 YDGEESCYII DAKLEGNLGR YLNHSCSPNL FVQNVFVDTH DLRFPWVAFF ASKRIRAGTE
1261 LTWDYNYEVG SVEGKELLCC CGAIECRGRL LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SETDB1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- testis: 21 nTPM
- thymus: 17 nTPM
- tonsil: 16 nTPM
- spleen: 16 nTPM
- endometrium: 15 nTPM
- lymph node: 15 nTPM
Single-cell type
- myonuclei: 83 nCPM
- sertoli cells: 74 nCPM
- adrenal cortex cells: 62 nCPM
- fibro-adipogenic progenitors: 61 nCPM
- retinal horizontal cells: 58 nCPM
- tuft cells: 58 nCPM
Immune cell
- intermediate monocyte: 11 nTPM
- myeloid DC: 8.7 nTPM
- non-classical monocyte: 7.9 nTPM
- classical monocyte: 7.1 nTPM
- naive B-cell: 6.7 nTPM
- basophil: 6.6 nTPM
Brain region
- cerebellum: 21 nTPM
- choroid plexus: 17 nTPM
- white matter: 17 nTPM
- cerebral cortex: 15 nTPM
- medulla oblongata: 15 nTPM
- thalamus: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SETDB1.
Disease | ImmuneIEDB
Conditions an epitope on SETDB1 was assayed in.
- hepatocellular carcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.2
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.01
- DepMap mean gene effect
- -0.4
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 18% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- DNA methylation-dependent constitutive heterochromatin formation
- heterochromatin organization
- methylation
- negative regulation of gene expression
- transposable element silencing by heterochromatin formation
Molecular functions
- chromatin binding
- DNA binding
- histone H3 methyltransferase activity
- histone H3K14ac reader activity
- histone H3K9 methyltransferase activity
- histone H3K9 monomethyltransferase activity
- histone H3K9 trimethyltransferase activity
- histone H3K9me2 methyltransferase activity
- histone H3K9me2/3 reader activity
- promoter-specific chromatin binding
- zinc ion binding
- histone H3K9 dimethyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SET domain
- Methyl-CpG DNA binding
- Tudor domain
- Post-SET domain
- Pre-SET domain
- DNA-binding domain superfamily
- SET domain superfamily
- Histone-lysine N-methyltransferase SETDB1/2-like, methyl-CpG binding domains
- Histone-lysine N-methyltransferase SETDB
- SET domain
- Methyl-CpG binding domain
- Pre-SET motif
- Histone-lysine N-methyltransferase SETDB1
- Domain of unknown function DUF5604
- Histone methyltransferase, Tudor domain 1
- Histone methyltransferase, Tudor domain 2
- Domain of unknown function (DUF5604)
- Histone methyltransferase Tudor domain
- Histone methyltransferase Tudor domain 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SETDB1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SETDB1 as an antibody target. Whether an autoantibody or antibody against SETDB1 could matter depends on whether native SETDB1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SETDB1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SETDB1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...